Eli Lilly Goochland County API Manufacturing Plant Investment

Deal value: $5,000,000,000

Eli Lilly announced a $5B investment to construct a new advanced API and injectable medicines manufacturing facility in Goochland County, Virginia. The plant will focus on cancer, autoimmune, and advanced therapies, supporting U.S. onshoring and supply chain resilience.

Eli Lilly's $5B investment in Goochland County is driven by the strategic need to expand advanced pharmaceutical manufacturing capacity in the U.S., focusing on cancer, autoimmune, and complex therapies. The timing reflects heightened demand for domestic supply chain resilience, onshoring critical drug production, and leveraging Virginia's skilled workforce and infrastructure. The core belief is that U.S.-based, state-of-the-art facilities are essential for innovation, security, and meeting future healthcare needs.